Atlas Trials

CD19/BCMA CAR-T Cell Therapy for Refractory/Moderate-to-severe Systemic Lupus Erythematosus

Clinical trial NCT06349343 · RECRUITING

Trial details

NCT number
NCT06349343
Sponsor
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Systemic Lupus Erythematosus
Start date
2025-02-10
Primary completion
2026-01-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.